Skip to main content
Top
Published in: Acta Diabetologica 1/2010

01-12-2010 | Original Article

Diabetes and the risk of sudden cardiac death, the Atherosclerosis Risk in Communities study

Authors: Anna M. Kucharska-Newton, David J. Couper, James S. Pankow, Ronald J. Prineas, Thomas D. Rea, Nona Sotoodehnia, Aravinda Chakravarti, Aaron R. Folsom, David S. Siscovick, Wayne D. Rosamond

Published in: Acta Diabetologica | Special Issue 1/2010

Login to get access

Abstract

Studies suggest that diabetes may specifically elevate the risk of sudden cardiac death in excess of other heart disease outcomes. In this study, we examined the association of type 2 diabetes with the incidence of sudden cardiac death when compared to the incidence of non-sudden cardiac death and non-fatal myocardial infarction (MI). We used data from the Atherosclerosis Risk in Communities (ARIC) study to examine the incidence of sudden and non-sudden cardiac death and non-fatal MI among persons with and without diabetes in follow-up from the baseline data collection (1987–1989) through December 31, 2001. There were 209 cases of sudden cardiac death, 119 of non-sudden cardiac death, and 739 of non-fatal MI identified in this cohort over an average 12.4 years of follow-up. In analyses adjusted for age, race/ARIC center, gender, and smoking, the Cox proportional hazard ratio of the association of baseline diabetes was 3.77 (95% CI 2.82, 5.05) for sudden cardiac death, 3.78 (95% CI 2.57, 5.53) for non-sudden cardiac death, and 3.20 (95% CI 2.71, 3.78) for non-fatal MI. Elevated risk for each of the three outcomes associated with diabetes was independent of adjustment for measures of blood pressure, lipids, inflammation, hemostasis, and renal function. Among those with diabetes, the risk of cardiac death, but not of non-fatal MI, was similar for men and women. Findings from this prospective, population-based cohort investigation indicate that diabetes does not confer a specific excess risk of sudden cardiac death. Our results suggest that diabetes attenuates gender differences in the risk of fatal cardiac events.
Literature
1.
go back to reference McGovern PG, Jacobs R, Shahar E et al (2001) Trends in Acute Coronary disease mortality, morbidity, and medical care from 1985 through 1997. Circulation 104:19–24CrossRefPubMed McGovern PG, Jacobs R, Shahar E et al (2001) Trends in Acute Coronary disease mortality, morbidity, and medical care from 1985 through 1997. Circulation 104:19–24CrossRefPubMed
2.
go back to reference Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M (1998) Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339:229–234CrossRefPubMed Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M (1998) Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339:229–234CrossRefPubMed
3.
go back to reference Albert CM, Chae CU, Grodstein F et al (2003) Prospective study of sudden cardiac death among women in the United States. Circulation 107:2096–2101CrossRefPubMed Albert CM, Chae CU, Grodstein F et al (2003) Prospective study of sudden cardiac death among women in the United States. Circulation 107:2096–2101CrossRefPubMed
4.
go back to reference Jouven X, Desnos M, Guerto C, Ducimetiere P (1999) Predicting sudden death in the population, the Paris prospective study I. Circulation 99:1978–1983PubMed Jouven X, Desnos M, Guerto C, Ducimetiere P (1999) Predicting sudden death in the population, the Paris prospective study I. Circulation 99:1978–1983PubMed
5.
go back to reference Jouven X, Lemaitre RN, Rea TD, Sotoodehnia N, Empana JP, Siscovick DS (2005) Diabetes, glucose level, and risk of sudden cardiac death. Eur Heart J 26:2142–2147CrossRefPubMed Jouven X, Lemaitre RN, Rea TD, Sotoodehnia N, Empana JP, Siscovick DS (2005) Diabetes, glucose level, and risk of sudden cardiac death. Eur Heart J 26:2142–2147CrossRefPubMed
6.
go back to reference Balkau B, Jouven X, Ducimetiere P, Eschwege E (1999) Diabetes as a risk factor for sudden death. Lancet 354:1968–1969CrossRefPubMed Balkau B, Jouven X, Ducimetiere P, Eschwege E (1999) Diabetes as a risk factor for sudden death. Lancet 354:1968–1969CrossRefPubMed
7.
go back to reference The ARIC Investigators (1989) The Atherosclerosis risk in communities (ARIC) study: design and objectives. Am J Epidemiol 129:687–702 The ARIC Investigators (1989) The Atherosclerosis risk in communities (ARIC) study: design and objectives. Am J Epidemiol 129:687–702
8.
go back to reference Warnick GR, Mayfield C, Benderson J, Chen JS, Albers JJ (1982) HDL cholesterol quantitation by phosphotungstate-Mg2+ and by dextran sulfate-Mn2+-polyethylene glycol precipitation, both with enzymic cholesterol assay compared with the lipid research method. Am J Clin Pathol 78:718–723PubMed Warnick GR, Mayfield C, Benderson J, Chen JS, Albers JJ (1982) HDL cholesterol quantitation by phosphotungstate-Mg2+ and by dextran sulfate-Mn2+-polyethylene glycol precipitation, both with enzymic cholesterol assay compared with the lipid research method. Am J Clin Pathol 78:718–723PubMed
9.
go back to reference Siedel J, Hagele EO, Ziegenhorn J, Wahlefeld AW (1983) Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. Clin Chem 29:1075–1080PubMed Siedel J, Hagele EO, Ziegenhorn J, Wahlefeld AW (1983) Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. Clin Chem 29:1075–1080PubMed
10.
go back to reference Lustgarten JA, Wenk RE (1972) Simple, rapid, kinetic method for serum creatinine measurement. Clin Chem 18:1419–1422PubMed Lustgarten JA, Wenk RE (1972) Simple, rapid, kinetic method for serum creatinine measurement. Clin Chem 18:1419–1422PubMed
11.
go back to reference Manjunath G, Tighiouart H, Ibrahim H et al (2003) Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol 41:47–55CrossRefPubMed Manjunath G, Tighiouart H, Ibrahim H et al (2003) Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol 41:47–55CrossRefPubMed
12.
go back to reference Papp AC, Hatzakis H, Bracey A, Wu KK (1989) ARIC hemostasis study–I. Development of a blood collection and processing system suitable for multicenter hemostatic studies. Thromb Haemost 61:15–19PubMed Papp AC, Hatzakis H, Bracey A, Wu KK (1989) ARIC hemostasis study–I. Development of a blood collection and processing system suitable for multicenter hemostatic studies. Thromb Haemost 61:15–19PubMed
13.
go back to reference Duncan BB, Schmidt MI, Pankow JS et al (2003) Low-grade systemic inflammation and the development of type 2 diabetes—the atherosclerosis risk in communities study. Diabetes 52:1799–1805CrossRefPubMed Duncan BB, Schmidt MI, Pankow JS et al (2003) Low-grade systemic inflammation and the development of type 2 diabetes—the atherosclerosis risk in communities study. Diabetes 52:1799–1805CrossRefPubMed
14.
go back to reference White AD, Rosamond WD, Chambless LE et al (1999) Sex and race differences in short-term prognosis after acute coronary heart disease events: the Atherosclerosis risk in communities (ARIC) study. Am Heart J 138:540–548CrossRefPubMed White AD, Rosamond WD, Chambless LE et al (1999) Sex and race differences in short-term prognosis after acute coronary heart disease events: the Atherosclerosis risk in communities (ARIC) study. Am Heart J 138:540–548CrossRefPubMed
15.
go back to reference Eriksson H, Caidahl K, Larsson B et al (1987) Cardiac and pulmonary causes of dyspnoea–validation of a scoring test for clinical-epidemiological use: the study of men born in 1913. Eur Heart J 8:1007–1014PubMed Eriksson H, Caidahl K, Larsson B et al (1987) Cardiac and pulmonary causes of dyspnoea–validation of a scoring test for clinical-epidemiological use: the study of men born in 1913. Eur Heart J 8:1007–1014PubMed
16.
go back to reference Mickey RM, Greenland S (1989) The impact of confounder selection criteria on effect estimation. Am J Epidemiol 129:125–137PubMed Mickey RM, Greenland S (1989) The impact of confounder selection criteria on effect estimation. Am J Epidemiol 129:125–137PubMed
17.
go back to reference Allison P (1995) Survival Analysis Using SAS, a practical guide. SAS Institute, Cary Allison P (1995) Survival Analysis Using SAS, a practical guide. SAS Institute, Cary
18.
go back to reference Kannel WB, Schatzkin A (1985) Sudden death: lessons from subsets in population studies. J Am Coll Cardiol 5:141B–149BCrossRefPubMed Kannel WB, Schatzkin A (1985) Sudden death: lessons from subsets in population studies. J Am Coll Cardiol 5:141B–149BCrossRefPubMed
19.
go back to reference Escobedo LG, Caspersen CJ (1997) Risk factors for sudden coronary death in the United States. Epidemiology 8:175–180CrossRefPubMed Escobedo LG, Caspersen CJ (1997) Risk factors for sudden coronary death in the United States. Epidemiology 8:175–180CrossRefPubMed
20.
go back to reference Dale AC, Nilsen TI, Vatten L, Midthjell K, Wiseth R (2007) Diabetes mellitus and risk of fatal ischaemic heart disease by gender: 18 years follow-up of 74, 914 individuals in the HUNT 1 study. Eur Heart J 28:2924–2929CrossRefPubMed Dale AC, Nilsen TI, Vatten L, Midthjell K, Wiseth R (2007) Diabetes mellitus and risk of fatal ischaemic heart disease by gender: 18 years follow-up of 74, 914 individuals in the HUNT 1 study. Eur Heart J 28:2924–2929CrossRefPubMed
21.
go back to reference Juutilainen A, Kortelainen S, Lehto S, Ronnemaa T, Pyorala K, Laakso M (2004) Gender difference in the impact of type 2 diabetes on coronary heart disease risk. Diabetes Care 27:2898–2904CrossRefPubMed Juutilainen A, Kortelainen S, Lehto S, Ronnemaa T, Pyorala K, Laakso M (2004) Gender difference in the impact of type 2 diabetes on coronary heart disease risk. Diabetes Care 27:2898–2904CrossRefPubMed
22.
go back to reference Ford ES, Capewell S (2007) Coronary heart disease mortality among young adults in the U.S. From 1980 through 2002: concealed leveling of mortality rates. J Am Coll Cardiol 50:2128–2132CrossRefPubMed Ford ES, Capewell S (2007) Coronary heart disease mortality among young adults in the U.S. From 1980 through 2002: concealed leveling of mortality rates. J Am Coll Cardiol 50:2128–2132CrossRefPubMed
23.
go back to reference Zheng Z-J, Croft JB, Giles WH, Mensah GA (2001) Sudden cardiac death in the United States, 1989 to 1998. Circulation 104:2158–2163CrossRefPubMed Zheng Z-J, Croft JB, Giles WH, Mensah GA (2001) Sudden cardiac death in the United States, 1989 to 1998. Circulation 104:2158–2163CrossRefPubMed
24.
go back to reference Pankow JS, Kwan DK, Duncan BB et al (2007) Cardiometabolic risk in impaired fasting glucose and impaired glucose tolerance: the atherosclerosis risk in communities study. Diabetes Care 30:325–331CrossRefPubMed Pankow JS, Kwan DK, Duncan BB et al (2007) Cardiometabolic risk in impaired fasting glucose and impaired glucose tolerance: the atherosclerosis risk in communities study. Diabetes Care 30:325–331CrossRefPubMed
Metadata
Title
Diabetes and the risk of sudden cardiac death, the Atherosclerosis Risk in Communities study
Authors
Anna M. Kucharska-Newton
David J. Couper
James S. Pankow
Ronald J. Prineas
Thomas D. Rea
Nona Sotoodehnia
Aravinda Chakravarti
Aaron R. Folsom
David S. Siscovick
Wayne D. Rosamond
Publication date
01-12-2010
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue Special Issue 1/2010
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-009-0157-9

Other articles of this Special Issue 1/2010

Acta Diabetologica 1/2010 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.